People · Operator
Named in public records as an officer, director or promoter · active 2012–2013 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Precision Biologics, Inc. | — | Biotechnology | Series C | $75.2M | $2.2B | 2012 |
Robert A Washington at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert A Washington on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick M. Soon-Shiong | 1 | 2 |
| Stanley B Archibald, Jr. | 1 | 1 |
| Mark B Kristen | 1 | 1 |
| Sheldon B Rabin | 1 | 1 |
| Albine K Martin | 1 | 1 |
| R.J. B Childress | 1 | 1 |
| C. Brent Haggard | 1 | 1 |
| Severin B Russo | 1 | 1 |
| Christian M. Zapf | 1 | 1 |
| Philip M Arlen | 1 | 1 |
| Charles M. Kim | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.